| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 15 |
| 1 | MACITENTAN | 14 |
| 2 | TREPROSTINIL | 11 |
| 3 | TADALAFIL | 10 |
| 4 | SILDENAFIL CITRATE | 8 |
| 5 | AMBRISENTAN | 6 |
| 6 | RIOCIGUAT | 6 |
| 7 | SILDENAFIL | 6 |
| 8 | 0XYGEN | 5 |
| 9 | OXYGEN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 15 | 0.0011 |
| 1 | SODIUM CITRATE | 1 | 0.0008 |
| 2 | DOBUTAMINE HYDROCHLORIDE | 1 | 0.0008 |
| 3 | CEFACLOR | 1 | 0.0006 |
| 4 | SENNOSIDES A AND B | 1 | 0.0006 |
| 5 | TRABECTEDIN | 1 | 0.0004 |
| 6 | CALCIUM POLYCARBOPHIL | 1 | 0.0003 |
| 7 | LEVOCARNITINE | 1 | 0.0003 |
| 8 | FOSCARBIDOPA/FOSLEVODOPA | 2 | 0.0002 |
| 9 | MACITENTAN | 14 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 1 | Soluble Guanylate Cyclase Stimulator [EPC] | 6 | 0.0002 |
| 2 | Prostacycline Vasodilator [EPC] | 22 | 0.0002 |
| 3 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 4 | Vitamin K [EPC] | 1 | 0.0001 |
| 5 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 13 | 0.0001 |
| 7 | Endothelin Receptor Antagonist [EPC] | 19 | 0.0001 |
| 8 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |
| 9 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |